In this most recent study, the researchers analyzed the various mechanical changes to breast cancer cells in which myoferlin levels were dramatically reduced compared to
normal breast cancer cells.
In addition to using
normal breast cancer cells in the experiments, the team also used cancer cells that had been genetically engineered to lack either GSTO1 or RYR1.
Not exact matches
Many women find their own
breast cancers, but it is something they notice as part of their
normal activities, not during a
breast self - exam.
However, the rats are protected from
breast cancer long after hormone levels return to
normal.
And because mouse embryo cells with inactivated copies of BRCA2 are more sensitive to ionizing radiation than
normal cells are, «it's a reasonable extrapolation» that
breast cancers with mutated copies of the gene may be especially good candidates for radiation therapy.
If a
breast cancer line had silently contaminated Klonisch's cell culture early on, it would have been subject to the usual technique for immortalizing a
normal cell (which involves applying enzymes, antibiotics and antibiotic - resistant genes).
Being obese or having a higher body mass index (BMI) while carrying a BRCA (
BReast CAncer gene) mutation is positively linked with higher levels of damage to the DNA in normal breast gland cells, new research sug
BReast CAncer gene) mutation is positively linked with higher levels of damage to the DNA in
normal breast gland cells, new research sug
breast gland cells, new research suggests.
Plakoglobin is a component of two important structures involved in cell - to - cell adhesion, and the investigators found that suppressing its expression caused CTC clusters to fall apart, reducing their metastatic potential, and also disrupted cell - to - cell contact between
breast cancer cells but not
normal breast tissue.
Their research, published in PLOS ONE, focused on one particular gene — TRIM29 — selected from a pool of 100 genes with regulatory patterns specific to
normal breast tissue, to prove the link between
breast - specific genes and the pathology of
cancer.
In this particular case, the researchers used DESI mass spectrometry imaging to look at the distribution and amounts of fatty acid substances, called lipids, within
breast tissue and
normal tissue from 61 samples obtained from 14
breast cancer patients that underwent mastectomy.
A well known example is estrogen, which is involved in the
normal differentiation of the
breast and also in
breast cancer development,» said Dr. Evron, a senior oncologist and a researcher in the lab.
«
Normal breast epithelium from the duct giving rise to a
breast cancer has not been previously studied in this way.»
«
Breast cancer researchers track changes in
normal mammary duct cells leading to disease.»
Breast cancer researchers have mapped early genetic alterations in
normal - looking cells at various distances from primary tumours to show how changes along the lining of mammary ducts can lead to disease.
The researchers found that several fatty acids, such as oleic acid, were more abundant in
breast cancer tissue compared to
normal tissue.
The team therefore analyzed the case history of 890
breast cancer patients and found that low Numb - 1 and -2 levels correlated with an increased risk of aggressive, metastatic disease, particularly for the luminal subtype of
breast cancers, which tend to retain a
normal, functional copy of the p53 gene.
Among postmenopausal women with
normal body mass index (BMI), those with higher body fat levels had an increased risk for invasive
breast cancer, according to data presented at the American Association for Cancer Research Special Conference Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27
cancer, according to data presented at the American Association for
Cancer Research Special Conference Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27
Cancer Research Special Conference Obesity and
Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27
Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27 - 30.
«High body fat levels associated with increased
breast cancer risk in women with
normal BMI.»
«Our findings show that the risk of invasive
breast cancer is increased in postmenopausal women with
normal BMI and higher levels of body fat, meaning that a large proportion of the population has an unrecognized risk of developing
cancer.»
The study included participants who had a
normal BMI (between 18.5 to < 25.0) with baseline DXA measurements and no history of
breast cancer.
Iyengar and colleagues also found that the risk of ER - positive
breast cancer increased by 35 percent for each 5 - kilogram increase in whole body fat, despite having a
normal BMI.
Zeroing in on this kinase was encouraging, Goga said, because other researchers have shown that genetic - knockout mice that lack the entire family of PIM kinases are slightly smaller than
normal mice, but «basically fine,» indicating that a drug targeting just PIM1 may have manageable levels of toxicity in
breast cancer patients.
The second collection comprised data from 311 manually curated
breast cancer and normal samples from The Cancer Genome Atlas repository at the National Institutes of Health
cancer and
normal samples from The
Cancer Genome Atlas repository at the National Institutes of Health
Cancer Genome Atlas repository at the National Institutes of Health (NIH).
By manipulating it in vitro, a team of researchers led by Prof. David Mooney at Harvard SEAS have identified a possible mechanism by which
normal cells turn malignant in mammary epithelial tissues, the tissues frequently involved in
breast cancer.
Now, results of a new study by Johns Hopkins Kimmel
Cancer Center scientists suggests a powerful role for the protein in
normal breast cells, acting as a tumor suppressor that halts abnormal cell growth.
The researchers found that over 25 percent of index patients with
normal results from commercial testing of BRCA1 and BRCA2, but with families severely affected by
breast cancer, could be resolved by sequencing all genes known to be involved in
breast cancer.
In some families, the patient who was tested had
normal sequences of BRCA1 and BRCA2, but her relatives with
breast cancer carried a mutation in one of those genes.
They conducted complete genomic sequencing of all genes implicated in
breast cancer on DNA samples from
breast cancer patients who had
normal BRCA1 and BRCA2 commercial test results.
The 5E5 antibody recognized multiple types of
cancer cells, including leukemia, ovarian,
breast, and pancreatic
cancer cells, but not
normal tissues.
The researchers identified a protein, SOCS3, that is highly expressed in
normal cells but undetectable in triple - negative
breast cancer.
Obesity is associated in general with
cancer, but the link with
breast cancer is especially striking: In one recent large study, the most overweight women were at a 58 % higher risk than women of
normal weight.
The news wasn't all bad: When Fischbach's team put obese mice on a diet, their mammary fat tissue had fewer myofibroblasts, suggesting losing weight could make a woman's fat tissue structure more
normal and lower her
breast cancer risk.
The research, using cells from the
Breast Cancer Now Tissue Bank and due to be published in Nature Communications, also shows that the epigenetic changes are inherited as long as the cell divides, and that the team's manipulations permanently and negatively affected the biology of a normal breast cell from a healthy indiv
Breast Cancer Now Tissue Bank and due to be published in Nature Communications, also shows that the epigenetic changes are inherited as long as the cell divides, and that the team's manipulations permanently and negatively affected the biology of a
normal breast cell from a healthy indiv
breast cell from a healthy individual.
Dr. David Gilley's laboratory at the Indiana University School of Medicine in Indianapolis and Dr. Connie Eaves» laboratory at the BC
Cancer Agency's Terry Fox Laboratory in Vancouver, Canada, collaborated to determine how telomeres are regulated in different types of
normal breast cells.
New research provides critical insights into how
normal breast precursor cells may be genetically vulnerable to develop into
cancer.
The researchers inserted between 10,000 and 40,000 of these small RNAs at once into
breast cancer, colon
cancer, and
normal human cells in the lab.
Interestingly, the team found that radiologists could do better than chance in discriminating
breast cancer cases from
normal tissue, even when the images of abnormal
breast tissue did not directly capture a cancerous lesion or when those images were taken from the contralateral
breast (the
breast on the other side of the body) of a woman with
breast cancer.
«Radiologists detect
breast cancer in «blink of an eye»: Study investigates how trained radiologists are able to distinguish
normal from abnormal mammograms when shown images for only half a second.»
This compound killed human
breast, prostate, lung, and liver
cancer cells, while sparing
normal cells.
Quantification of cellular volume and sub-cellular density fluctuations: comparison of
normal peripheral blood cells and circulating tumor cells identified in a
breast cancer patient.
Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair defic
Cancer stem cell markers are enriched in
normal tissue adjacent to triple negative
breast cancer and inversely correlated with DNA repair defic
cancer and inversely correlated with DNA repair deficiency.
It may explain why 77 percent of
breast cancers have a
normal p53 gene, and it further suggests a way that
cancer cells can use both to metastasize and survive the journey to organs where they set up a new home.
The key was the development of a special «birdcage» coil for MRI of the mouse mammary glands, and the team began testing a wide range of protocols to get images that could distinguish between
cancer,
normal breast tissue and fat.
The team examined premalignant as well as
cancer cells from
breast and lung tumors and matched
normal and premalignant
breast cells from healthy women provided by scientists at the University of California San Francisco.
December 20, 2007 Genetic alterations in the benign - appearing stromal cells surrounding
breast cancers predict for nodal metastases The cells surrounding
breast cancers, called stroma, are benign appearing, «
normal» by all accounts.
LA JOLLA, CA — Reviving a theory first proposed in the late 1800s that the development of organs in the
normal embryo and the development of
cancers are related, scientists at the Salk Institute for Biological Studies have studied organ development in mice to unravel how
breast cancers, and perhaps other
cancers, develop in people.
Using cutting - edge techniques enabled by next - generation sequencing, the authors generated complete methylome maps at single nucleotide resolution in a low - passage
breast cancer cell line and
normal breast tissue (primary human mammary epithelial cells).
This is a color - coded view of a
normal breast, left, and a
breast with
cancer, right.
Exposures to chemicals that disrupt these
normal processes can alter
normal breast development in ways that lead to increased risk of
breast cancer in later life.
To evaluate whether altered expression of the ABL genes is associated with
breast cancer progression and metastasis, we examined the expression of ABL1 and ABL2 in normal and invasive breast tumor specimens using published TCGA (The Cancer Genome Atlas) data sets (14 &mdash
cancer progression and metastasis, we examined the expression of ABL1 and ABL2 in
normal and invasive
breast tumor specimens using published TCGA (The
Cancer Genome Atlas) data sets (14 &mdash
Cancer Genome Atlas) data sets (14 — 16).